Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients
Young Kul Jung, Jong Eun Yeon, Kwang Gyun Lee, Eun Seok Jung, Jeong Han Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Sun Ho Um, Ho Sang Ryu, Kwan Soo Byun
Korean J Hepatol. 2011;17(4):261-267. Published online 2011 Dec 26 DOI: https://doi.org/10.3350/kjhep.2011.17.4.261
Citations to this article as recorded by 
Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis
Yuhao Yao, Jiaxin Zhang, Xiaoke Li, Xiaobin Zao, Xu Cao, Guang Chen, Yong'an Ye
Frontiers in Public Health.2022;[Epub] CrossRef
Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B
Issam Tout, Pietro Lampertico, Thomas Berg, Tarik Asselah
Antiviral Research.2021; 185: 104992. CrossRef
Challenges in the discontinuation of chronic hepatitis B antiviral agents
Apichat Kaewdech, Pimsiri Sripongpun
World Journal of Hepatology.2021; 13(9): 1042. CrossRef
Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis B
Florian van Bömmel, Thomas Berg
Hepatology Communications.2021; 5(10): 1632. CrossRef
Stopping long‐term treatment with nucleos(t)ide analogues is a favourable option for selected patients with HBeAg‐negative chronic hepatitis B
Florian van Bömmel, Thomas Berg
Liver International.2018; 38(S1): 90. CrossRef
Why not to stop antiviral treatment in patients with chronic hepatitis B
Sebastián Marciano, Adrián Gadano
Liver International.2018; 38(S1): 97. CrossRef
Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
Elia Moreno-Cubero, Robert T Sánchez del Arco, Julia Peña-Asensio, Eduardo Sanz de Villalobos, Joaquín Míquel, Juan Ramón Larrubia
World Journal of Gastroenterology.2018; 24(17): 1825. CrossRef
Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients
Kyu Sik Jung, Jun Yong Park, Young Eun Chon, Hyon-Suk Kim, Wonseok Kang, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Kwang-Hyub Han, Sang Hoon Ahn
Journal of Gastroenterology.2016; 51(8): 830. CrossRef
Discontinuation of oral antivirals in chronic hepatitis B: A systematic review
George Papatheodoridis, Ioannis Vlachogiannakos, Evangelos Cholongitas, Karsten Wursthorn, Christos Thomadakis, Giota Touloumi, Jörg Petersen
Hepatology.2016; 63(5): 1481. CrossRef
Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
Wai-Kay Seto, Aric Josun Hui, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Kevin Sze-Hang Liu, Ching-Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan
Gut.2015; 64(4): 667. CrossRef